Veracyte Is Maintained at Underweight by Morgan Stanley

Dow JonesNov 18 23:41 · Ratings

Express News | Veracyte Inc : Morgan Stanley Raises Target Price to $28 From $26

BreakingsNov 18 18:21

Sell Rating on Veracyte: Strong Performance Overshadowed by Limited Immediate Upside

TipRanksNov 18 18:11 · Ratings

Wolfe Research Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $50

Futu NewsNov 15 19:34 · Ratings

Veracyte Insider Sold Shares Worth $585,663, According to a Recent SEC Filing

MT NewswiresNov 15 05:45

ARKK's Holdings Ranked by SA Quant Grades

Seeking AlphaNov 13 03:21